Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: Identifying Individuals at Risk of Glucocorticoid-Induced Impairment of Bone Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating methods to identify individuals at risk of glucocorticoid-induced osteoporosis. Sponsored by Odense University Hospital, the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Odense University Hospital | Conditions: Osteoporosis Secondary | Phase 2 | Status: ACTIVE_NOT_RECRUITING